|
MCFD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.715800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.337000E-01 |
| Normal-vs-Stage2 |
1.022230E-01 |
| Normal-vs-Stage3 |
2.712000E-02 |
| Normal-vs-Stage4 |
2.859600E-01 |
| Stage1-vs-Stage2 |
1.159620E-01 |
| Stage1-vs-Stage3 |
5.582300E-02 |
| Stage1-vs-Stage4 |
2.776000E-01 |
| Stage2-vs-Stage3 |
6.451200E-01 |
| Stage2-vs-Stage4 |
9.424400E-01 |
| Stage3-vs-Stage4 |
6.698600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.981800E-03 |
| Normal-vs-AfricanAmerican |
1.877210E-01 |
| Normal-vs-Asian |
7.143800E-01 |
| Caucasian-vs-AfricanAmerican |
7.123800E-01 |
| Caucasian-vs-Asian |
8.695600E-01 |
| AfricanAmerican-vs-Asian |
9.685200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.180400E-01 |
| Normal-vs-Female |
9.9913000000007E-05 |
| Male-vs-Female |
1.396070E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.939800E-01 |
| Normal-vs-Extreme_Weight |
7.047200E-01 |
| Normal-vs-Obese |
3.184900E-03 |
| Normal-vs-Extreme_Obese |
9.019800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.603600E-01 |
| Normal_Weight-vs-Obese |
6.583700E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.072800E-01 |
| Extreme_Weight-vs-Obese |
3.757900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.723000E-01 |
| Obese-vs-Extreme_Obese |
2.619400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.117600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.390600E-04 |
| Normal-vs-Age(61-80Yrs) |
4.206000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.257600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.986800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.357800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.228770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.276300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.949400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.300600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.548000E-02 |
| Normal-VS-Type2 PRCC |
2.272600E-01 |
| Normal-VS-KIRP CIMP |
3.581900E-03 |
| Normal-VS-Unclassified PRCC |
9.941300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.379400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.26900000002794E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
6.251700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.978800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.081900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.165700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.450600E-01 |
| Normal-vs-N1 |
1.178020E-02 |
| Normal-vs-N2 |
1.355650E-01 |
| N0-vs-N1 |
1.268300E-02 |
| N0-vs-N2 |
4.323400E-03 |
| N1-vs-N2 |
5.720600E-01 |
|
|
